Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Peroxisome proliferator activated receptor-γ agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation.
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression.
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
[Microglia in neuroimmunological disorders].
Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.
Robotic gait rehabilitation and substitution devices in neurological disorders: where are we now?
MS Trust critical of guidance on multiple sclerosis.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosis.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
Role of SIRT1 in autoimmune demyelination and neurodegeneration.
Bone mineral density levels in adults with multiple sclerosis: A meta-analysis.
Presentation of multiple sclerosis with comorbid Huntington's disease.
Multiple sclerosis and the role of immune cells.
iNKT-cells and their ligands: focus on multiple sclerosis.
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): a single case report follow-up study.
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement Project.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
PERK Activation Preserves the Viability and Function of Remyelinating Oligodendrocytes in Immune-Mediated Demyelinating Diseases.
Pages
« first
‹ previous
…
571
572
573
574
575
576
577
578
579
…
next ›
last »